WCG IRB, fomerly Western IRB (WIRB), is an independent commercial IRB located in Puyallop, WA, has been contracted to act as one of RowanSOM's IRB to review, approve and monitor industry-sponsored human subjects research.

All submissions to WCG must go through the RowanSOM IRB Office.

Submission of WCG applications must be submitted electronically through the Cayuse IRB system. Click here to go to the Cayuse IRB system and submit the WCG application.

Click here for WCG IRB instructions, guidelines, and requirements

Criteria for submission of studies for review by WCG

  • Study is industry-sponsored, that is, the industry sponsor has written the protocol, is funding the research, and will monitor the conduct of the study.
  • The research will be conducted at a RowanSOM performance site. (Site is owned and operated by RowanSOM)
  • The investigator(s) is (are) RowanSOM employees
  • The investigator(s) is (are) in good standing with the RowanSOM IRB (e.g., no compliance issues, no expired studies, etc.)
  • All study personnel involved in human subjects research have completed the Collaborative Institutional Training Initiative (CITI) Basic Course.

Circumstances Requiring Review of Protocols by the RowanSOM IRB

Under the following circumstances, protocols may not be reviewed by WCG, but must be reviewed by RowanSOM IRB:

  • the research will be conducted at a non-RowanSOM performance site.
  • the research will have or could be perceived as having significant local impact on the University’s host communities, requiring special sensitivity to the University’s host communities’ attitudes and culture, and/or sufficient knowledge of the local research context.
  • the research will be conducted by investigators who have current compliance issues or are otherwise not in good standing with a RowanSOM IRB.
  • research requiring Institutional Biosafety oversight, such as research involving the following:
    • Infectious agents,
    • Recombinant DNA/human gene transfer,
    • or Biologically-derived toxins